Funds a Clinical Coordinating Center to lead multi-site clinical trials using innovative designs, focusing on NHLBI’s mission and health outcome disparities.
NHLBI plans to fund single-site clinical trials (R61/R33) testing therapeutic, behavioral, or prevention strategies, encouraging innovative designs.
NIH will fund investigator-initiated multi-site or decentralized clinical trials relevant to its mission, supporting planning and implementation over up to 7 years using a milestone-driven UG3/UH3 grant mechanism.
This grant will fund a single Coordinating Center to manage research resources, data, and collaboration for the Small Cell Lung Cancer Consortium over five years.
This grant funds centers that provide specialized research services and training to external investigators in areas related to NIDDK’s mission, such as obesity and diabetes, to enhance research rigor and efficiency.